Saudi Arabia Lung Cancer Diagnostics Market to 2032
Overview
The Saudi Arabia Lung Cancer Diagnostics Market is expected to reach a 43.70 USD Billion by 2032 and is projected to grow at a CAGR of 12.81% from 2025 to 2032.
Saudi Arabia Lung Cancer Diagnostics Market 2018-2032 USD Billion
Saudi Arabia Lung Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 21.29 USD Billion
- Projected Market Size (2032): 43.70 USD Billion
- CAGR (2025-2032): 12.81%
Key Findings of Saudi Arabia Lung Cancer Diagnostics Market
- The Saudi Arabia Lung Cancer Diagnostics Market was valued at 21.29 USD Billion in 2024.
- The Saudi Arabia Lung Cancer Diagnostics Market is likely to grow at a CAGR of 12.81% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 17.16 USD Billion
- The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 14.25% during the forecast period from 2024 to 2032.
Saudi Arabia Lung Cancer Diagnostics Market Scope
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
- Retail Sales
- Direct Tender
- Consumables & Accessories
- Instruments
Saudi Arabia Lung Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 21.29 USD Billion |
| Market Value in 2032 | 43.70 USD Billion |
| CAGR (2025-2032) | 12.81% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Test,Cancer,End User,Distribution Channel,Product |
Regional Insights:
-
Leading Market (2024-2032): Saudi Arabia, leading in terms of revenue 21.29 USD Billion in 2024
- Key Country: Saudi Arabia, leading in terms of revenue with value of 21.29 USD Billion in 2024.
Segments and Scope
-
Saudi Arabia Lung Cancer Diagnostics Market to 2032, By Test
- Imaging Test is the largest segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a revenue of 12.21 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a Growth rate of 13.61 % in forecast period 2025-2032.
-
Saudi Arabia Lung Cancer Diagnostics Market to 2032, By Cancer
- Non-Small Cell Lung Cancer is the largest segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a revenue of 17.16 USD Billion in the year 2024.
- Non-Small Cell Lung Cancer is the Fastest growing segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a Growth rate of 13.01 % in forecast period 2025-2032.
-
Saudi Arabia Lung Cancer Diagnostics Market to 2032, By End User
- Hospital is the largest segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a revenue of 8.14 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a Growth rate of 14.25 % in forecast period 2025-2032.
-
Saudi Arabia Lung Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a revenue of 13.39 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a Growth rate of 13.74 % in forecast period 2025-2032.
-
Saudi Arabia Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a revenue of 14.79 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in Saudi Arabia Lung Cancer Diagnostics Market to 2032 with a Growth rate of 13.51 % in forecast period 2025-2032.
Saudi Arabia Lung Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
| Abbott | |||
| Guardant Health | |||
Saudi Arabia Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
Saudi Arabia Lung Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Saudi Arabia Lung Cancer Diagnostics Market Scope
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
- Retail Sales
- Direct Tender
- Consumables & Accessories
- Instruments
Frequently Asked Questions
Saudi Arabia Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.